Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)

Go back to Q3 Preview: Pfizer (PFE) Chugging Strong Into Earnings; M&A and Pipeline Key Focal Points (MRK, NVS)
Merck & Co. (NYSE: MRK) Delayed: 152.15 +3.16 (2.12%)
Previous Close $148.99    52 Week High $65.46 
Open $149.12    52 Week Low $47.97 
Day High $152.44    P/E 103.50 
Day Low $148.59    EPS $1.47 
Volume 2,156,172       

NOVARTIS AG (NYSE: NVS) Delayed: 157.63 +1.39 (0.89%)
Previous Close $156.24    52 Week High $89.15 
Open $156.17    52 Week Low $69.84 
Day High $157.75    P/E N/A 
Day Low $156.10    EPS $0.00 
Volume 146,733       

Pfizer Inc. (NYSE: PFE) Delayed: 28.20 +0.41 (1.48%)
Previous Close $27.79    52 Week High $37.39 
Open $27.77    52 Week Low $28.25 
Day High $28.21    P/E 17.09 
Day Low $27.66    EPS $1.65 
Volume 5,136,550